col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


78 Results       Page 1

 [1] 
American Society for Biochemistry and Molecular Biology: Journal of Biological Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2022―Jun―28 Correction: Exostosin glycosyltransferase 1 reduces porcine reproductive and respiratory syndrome virus infection through proteasomal degradation of nsp3 and nsp5 Xiaoxiao Zhang, Wenjuan Dong, Xun Wang, Zhenbang Zhu, Sheng He, Hui Zhang, et al. (+3)
2 [GO] 2022―May―11 Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2 Juliana C. Ferreira, Samar Fadl, Wael M. Rabeh
3 [GO] 2022―Apr―22 Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants Samantha E. Greasley, Stephen Noell, Olga Plotnikova, RoseAnn Ferre, Wei Liu, Ben Bolanos, et al. (+6)
4 [GO] 2022―Apr―10 Replication of the coronavirus genome: a paradox among positive-strand RNA viruses Emeline Grellet, India L’Hôte, Adeline Goulet, Isabelle Imbert
5 [GO] 2022―Mar―10 Prefusion Spike Protein Conformational Changes Are Slower in SARS-CoV-2 than in SARS-CoV-1 Vivek Govind Kumar, Dylan S. Ogden, Ugochi H. Isu, Adithya Polasa, James Losey, Mahmoud Moradi
6 [GO] 2022―Feb―17 Improved SARS-CoV-2 main protease high throughput screening assay using a 5-carboxyfluorescein substrate Scott Legare, Fabian Heide, Ben A. Bailey-Elkin, Jörg Stetefeld
7 [GO] 2022―Feb―11 SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer Kazuhiro Matsuoka, Nobuhiko Imahashi, Miki Ohno, Hirotaka Ode, Yoshihiro Nakata, Mai Kubota, et al. (+4)
8 [GO] 2022―Feb―10 Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2 Jiamnin Liu, Fan Lu, Yinghua Chen, Edward Plow, Jun Qin
9 [GO] 2022―Feb―07 The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling Juan Pablo Robles, Magdalena Zamora, Elva Adan-Castro, Lourdes Siqueiros-Marquez, Gonzalo Martinez de la Escalera, Carmen Clapp
10 [GO] 2022―Feb―04 Phase Separation by the SARS-CoV-2 Nucleocapsid Protein: Consensus and Open Questions Sean M. Cascarina, Eric D. Ross
11 [GO] 2022―Jan―30 Tafenoquine and its derivatives as inhibitors for the Severe Acute Respiratory Syndrome Coronavirus 2 Yeh Chen, Wen-Hao Yang, Hsiao-Fan Chen, Li-Min Huang, Jing-Yan Gao, Cheng-Wen Lin, et al. (+21)
12 [GO] 2022―Jan―25 Elimination of Aicardi Goutières Syndrome Protein SAMHD1 Activates Cellular Innate Immunity and Suppresses SARS-CoV-2 Replication Adrian Oo, Keivan Zandi, Caitlin Shepard, Leda C. Bassit, Katie Musall, Shu Ling Goh, et al. (+4)
13 [GO] 2022―Jan―13 Host E3 ligase HUWE1 attenuates the pro-apoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation Yuzheng Zhou, Rong Zheng, Sixu Liu, Cyrollah Disoma, Ashuai Du, Shiqin Li, et al. (+17)
14 [GO] 2021―Dec―28 Exostosin glycosyltransferase 1 reduces porcine reproductive and respiratory syndrome virus infection through proteasomal degradation of nsp3 and nsp5 Xiaoxiao Zhang, Wenjuan Dong, Xun Wang, Zhenbang Zhu, Sheng He, Hui Zhang, et al. (+3)
15 [GO] 2021―Dec―20 Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors Amanda A. Riccio, Eric D. Sullivan, William C. Copeland
16 [GO] 2021―Dec―18 The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms Giulia Paiardi, Stefan Richter, Pasqua Oreste, Chiara Urbinati, Marco Rusnati, Rebecca C. Wade
17 [GO] 2021―Nov―11 Proximity-dependent biotinylation detects associations between SARS coronavirus nonstructural protein 1 and stress granule-associated proteins Yevgeniy A. Gerassimovich, Samantha J. Miladinovski-Bangall, Kaitlin M. Bridges, Linkel Boateng, Lauren E. Ball, Homayoun Valafar, Anita Nag
18 [GO] 2021―Oct―29 A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein Dene R. Littler, Miaomiao Liu, Julie L. McAuley, Shea A. Lowery, Patricia T. Illing, Benjamin S. Gully, et al. (+6)
19 [GO] 2021―Oct―29 Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2 Rafael Bayarri-Olmos, Laust Bruun Johnsen, Anne Rosbjerg, Charlotte Helgstrand, Theresa Bak-Thomsen, Peter Garred, Mikkel-Ole Skjoedt
20 [GO] 2021―Oct―29 SARS-CoV-2 Beta Variant Substitutions Alter Spike Glycoprotein Receptor Binding Domain Structure and Stability Daniel L. Moss, Jay Rappaport
21 [GO] 2021―Oct―25 SARS-CoV-2 Y453F is not the “cluster 5” variant Ria Lassaunière
22 [GO] 2021―Oct―22 Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 Spike Glycoprotein George Stamatakis, Martina Samiotaki, Ioannis Temponeras, George Panayotou, Efstratios Stratikos
23 [GO] 2021―Oct―21 Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein Marion Gransagne, Gabriel Aymé, Sébastien Brier, Gaëlle Chauveau-Le Friec, Véronique Meriaux, Mireille Nowakowski, et al. (+16)
24 [GO] 2021―Oct―01 Exosome-mediated mRNA Delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity Shang Jui Tsai, Nadia A. Atai, Mafalda Cacciottolo, Justin Nice, Arjang Salehi, Chenxu Guo, et al. (+3)
25 [GO] 2021―Sep―24 D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation Tzu-Jing Yang, Pei-Yu Yu, Yuan-Chih Chang, Shang-Te Danny Hsu
26 [GO] 2021―Sep―23 An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15 Jason K. Perry, Todd C. Appleby, John P. Bilello, Joy Y. Feng, Uli Schmitz, Elizabeth A. Campbell
27 [GO] 2021―Sep―17 Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection Rohini Dwivedi, Priyanka Samanta, Poonam Sharma, Fuming Zhang, Sushil K. Mishra, Pavel Kucheryavy, et al. (+6)
28 [GO] 2021―Sep―17 Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants Vaibhav Upadhyay, Alexandra Lucas, Sudipta Panja, Ryuki Miyauchi, Krishna M.G. Mallela
29 [GO] 2021―Sep―07 Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif Ramiro Lorenzo, Lucas A. Defelipe, Lucio Aliperti, Stephan Niebling, Tânia F. Custódio, Christian Löw, et al. (+8)
30 [GO] 2021―Aug―31 Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2 Jérémie Prévost, Jonathan Richard, Romain Gasser, Shilei Ding, Clément Fage, Sai Priya Anand, et al. (+17)
31 [GO] 2021―Aug―27 SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity Adam S. Olia, Yaroslav Tsybovsky, Steven J. Chen, Cuiping Liu, Alexandra F. Nazzari, Li Ou, et al. (+13)
32 [GO] 2021―Aug―21 S-acylation of SARS-CoV-2 Spike Protein: Mechanistic Dissection, In Vitro Reconstitution and Role in Viral Infectivity Robbins Puthenveetil, Cheng Man Lun, R. Elliot Murphy, Liam B. Healy, Geraldine Vilmen, Eric T. Christenson, et al. (+2)
33 [GO] 2021―Aug―10 Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein Priyanka Chaurasia, Thi H.O. Nguyen, Louise C. Rowntree, Jennifer A. Juno, Adam K. Wheatley, Stephen J. Kent, et al. (+3)
34 [GO] 2021―Aug―06 Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action Egor P. Tchesnokov, Calvin J. Gordon, Emma Woolner, Dana Kocincova, Jason K. Perry, Joy Y. Feng, et al. (+2)
35 [GO] 2021―Aug―04 The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling Lilian Cristina Russo, Rebeka Tomasin, Isaac Araújo Matos, Antonio Carlos Manucci, Sven T. Sowa, Katie Dale, et al. (+6)
36 [GO] 2021―Jul―28 Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 non-structural protein 9 Dene R. Littler, Biswaranjan Mohanty, Shea A. Lowery, Rhys N. Colson, Benjamin S. Gully, Stanley Perlman, et al. (+2)
37 [GO] 2021―Jul―05 Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells James M. Hutchison, Ricardo Capone, Dustin D. Luu, Karan H. Shah, Arina Hadziselimovic, Wade D. Van Horn, Charles R. Sanders
38 [GO] 2021―Jun―30 Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection Rukmini Mukherjee, Anshu Bhattacharya, Denisa Bojkova, Ahmad Reza Mehdipour, Donghyuk Shin, Khadija Shahed Khan, et al. (+10)
39 [GO] 2021―Jun―20 Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion Chelsea T. Barrett, Hadley E. Neal, Kearstin Edmonds, Carole L. Moncman, Rachel Thompson, Jean M. Branttie, et al. (+4)
40 [GO] 2021―Jun―09 Decoding molnupiravir-induced mutagenesis in SARS-CoV-2 Luis Menéndez-Arias
41 [GO] 2021―May―31 Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2 Yan-Dong Tang
42 [GO] 2021―May―28 Role of host factors in SARS-CoV-2 entry John P. Evans, Shan-Lu Liu
43 [GO] 2021―May―27 Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2 Takuma Hayashi, Ikuo Konishi
44 [GO] 2021―May―23 Arginine Methylation of SARS-Cov-2 Nucleocapsid Protein Regulates RNA Binding, its Ability to Suppress Stress Granule Formation and Viral Replication Ting Cai, Zhenbao Yu, Zhen Wang, Chen Liang, Stéphane Richard
45 [GO] 2021―May―11 Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template Calvin J. Gordon, Egor P. Tchesnokov, Raymond F. Schinazi, Matthias Götte
46 [GO] 2021―May―07 The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection Anthony J. Carlos, Dat P. Ha, Da-Wei Yeh, Richard Van Krieken, Chun-Chih Tseng, Pu Zhang, et al. (+3)
47 [GO] 2021―Apr―23 Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells Alexander Carpinteiro, Barbara Gripp, Markus Hoffmann, Stefan Pöhlmann, Nicolas Hoertel, Michael J. Edwards, et al. (+4)
48 [GO] 2021―Apr―20 Downregulation of miR-218 by porcine reproductive and respiratory syndrome virus facilitates viral replication via inhibition of type I interferon responses Lin Zhang, Lu Zhang, Yu Pan, Junxin Gao, Yunfei Xu, Xi Li, et al. (+3)
49 [GO] 2021―Mar―12 The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization Rafael Bayarri-Olmos, Anne Rosbjerg, Laust Bruun Johnsen, Charlotte Helgstrand, Theresa Bak-Thomsen, Peter Garred, Mikkel-Ole Skjoedt
50 [GO] 2021―Feb―25 Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and Influenza virus Einat.B. Vitner, Hagit Achdout, Roy Avraham, Boaz Politi, Lilach Cherry, Hadas Tamir, et al. (+5)
51 [GO] 2021―Feb―24 Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species Hong-Liang Zhang, Yu-Ming Li, Jing Sun, Yu-Yuan Zhang, Tong-Yun Wang, Ming-Xia Sun, et al. (+6)
52 [GO] 2021―Feb―04 How glycobiology can help us treat and beat the COVID-19 pandemic Ricardo D. Lardone, Yohana C. Garay, Pedro Parodi, Sofia de la Fuente, Genaro Angeloni, Eduardo O. Bravo, et al. (+2)
53 [GO] 2021―Jan―30 Potent mouse monoclonal antibodies that block SARS-CoV-2 infection Youjia Guo, Atsushi Kawaguchi, Masaru Takeshita, Takeshi Sekiya, Mikako Hirohama, Akio Yamashita, et al. (+2)
54 [GO] 2021―Jan―19 SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis Armin Bayati, Rahul Kumar, Vincent Francis, Peter S. McPherson
55 [GO] 2021―Jan―18 The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 of mouse hepatitis virus and the maturation of coronavirus particles. R Repp, T Tamura, C B Boschek, H Wege, R T Schwarz, H Niemann
56 [GO] 2021―Jan―06 Signal recognition particle-dependent insertion of coronavirus E1, an intracellular membrane glycoprotein. P Rottier, J Armstrong, D I Meyer
57 [GO] 2021―Jan―06 O-glycosylation of the coronavirus M protein. Differential localization of sialyltransferases in N- and O-linked glycosylation. J.K. Locker, G Griffiths, M.C. Horzinek, P.J. Rottier
58 [GO] 2021―Jan―06 Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J.K. Locker, J.K. Rose, M.C. Horzinek, P.J. Rottier
59 [GO] 2021―Jan―05 Membrane integration and intracellular transport of the coronavirus glycoprotein E1, a class III membrane glycoprotein. T Mayer, T Tamura, M Falk, H Niemann
60 [GO] 2020―Dec―02 Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection Pablo Fuentes-Prior
61 [GO] 2020―Nov―24 The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles Bertrand Boson, Vincent Legros, Bingjie Zhou, Eglantine Siret, Cyrille Mathieu, François-Loïc Cosset, et al. (+2)
62 [GO] 2020―Nov―20 SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles Caroline B. Plescia, Emily A. David, Dhabaleswar Patra, Ranjan Sengupta, Souad Amiar, Yuan Su, Robert V. Stahelin
63 [GO] 2020―Oct―29 High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity Jinghua Lu, Peter D. Sun
64 [GO] 2020―Oct―19 Mouse Ifit1b is a cap1-RNA binding protein which inhibits mouse coronavirus translation and is regulated by complexing with Ifit1c Harriet V Mears, Trevor R Sweeney
65 [GO] 2020―Oct―15 Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography Daniel W. Kneller, Gwyndalyn Phillips, Kevin L Weiss, Swati Pant, Qiu Zhang, Hugh M O'Neill, et al. (+2)
66 [GO] 2020―Oct―14 Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity Collin D Heer, Daniel J Sanderson, Lynden S Voth, Yousef M.O. Alhammad, Mark S Schmidt, Samuel A.J. Trammell, et al. (+4)
67 [GO] 2020―Sep―25 Presence of hyaluronan in lung alveoli in severe Covid-19 - an opening for new treatment options? Urban Hellman, Mats G Karlsson, Anna Engström-Laurent, Sara Cajander, Luiza Dorofte, Clas Ahlm, et al. (+2)
68 [GO] 2020―Sep―24 Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action Egor P Tchesnokov, Calvin J Gordon, Emma Woolner, Dana Kocincova, Jason K Perry, Joy Y. Feng, et al. (+2)
69 [GO] 2020―Sep―11 Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2 Michael J. Edwards, Katrin Anne Becker, Barbara Gripp, Markus Hoffmann, Simone Keitsch, Barbara Wilker, et al. (+11)
70 [GO] 2020―Sep―04 A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits Samantha J. Mascuch, Sara Fakhretaha-Aval, Jessica C. Bowman, Minh Thu H. Ma, Gwendell Thomas, Bettina Bommarius, et al. (+29)
71 [GO] 2020―Aug―06 Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection Min Zheng, Evan Peter Williams, R. K. Subbarao Malireddi, Rajendra Karki, Balaji Banoth, Amanda Burton, et al. (+4)
72 [GO] 2020―Jun―25 SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics Ruchir Gupta, Jacob Charron, Cynthia L Stenger, Jared Painter, Hunter Steward, Taylor W Cook, et al. (+16)
73 [GO] 2020―Jun―25 Inhibition of SARS-CoV-2 by type I and type III interferons Ulrike Felgenhauer, Andreas Schoen, Hans Henrik Gad, Rune Hartmann, Andreas R Schaubmar, Klaus Failing, et al. (+2)
74 [GO] 2020―Jun―23 Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2) Jamie A. Kelly, Alexandra N. Olson, Krishna Neupane, Sneha Munshi, Josue San Emeterio, Lois Pollack, et al. (+2)
75 [GO] 2020―Apr―13 Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency Calvin J Gordon, Egor P Tchesnokov, Emma Woolner, Jason K Perry, Joy Y. Feng, Danielle P Porter, Matthias Gotte
76 [GO] 2020―Apr―10 Halting coronavirus polymerase Robert N. Kirchdoerfer
77 [GO] 2020―Feb―25 The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus Calvin J Gordon, Egor P Tchesnokov, Joy Y. Feng, Danielle P Porter, Matthias Gotte
78 [GO] 2019―Dec―28 Pulmonary Surfactant Lipids Inhibit Infections with the Pandemic H1N1 Influenza Virus in Several Animal Models Mari Numata, James R Mitchell, Jennifer L Tipper, Jeffery D Brand, John E Trombley, Yoji Nagashima, et al. (+4)
 [1] 

78 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec